Research tools
Analyst Ratings Screener
Find recent upgrades, downgrades, initiations, and reiterations by firm, rating, consensus, target upside, sector, and company size.
Save your best screens
Sign in to keep filters and sorting ready for your next visit.
3,894 matching rating changes
Export CSV| Date, sort lowest first | Symbol | Company | Firm | Action | Prior rating | New rating | Consensus | Analysts, sort highest first | Avg. target | Target upside, sort highest first | Market cap, sort highest first |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | CTVA | Corteva, Inc. | UBS | Main | Neutral | Neutral | Buy | 13 | $80.83 | -2.10% | 44.62B |
| Aug 18, 2026 | DCGO | DocGo Inc. | Canaccord Genuity | Main | Hold | Hold | — | — | $1.50 | +299.79% | 91.93M |
| Aug 18, 2026 | DCGO | DocGo Inc. | Needham | Reiterated | Buy | Buy | — | — | $1.50 | +299.79% | 91.93M |
| Aug 18, 2026 | DK | Delek US Holdings, Inc. | Goldman Sachs | Main | Buy | Buy | — | — | $39.00 | -47.63% | 2.05B |
| Aug 18, 2026 | DLR | Digital Realty Trust, Inc. | Evercore ISI Group | Main | Outperform | Outperform | Buy | 22 | $193.17 | +7.83% | 54.54B |
| Aug 18, 2026 | DOCU | DocuSign, Inc. | Citizens | Reiterated | Market Outperform | Market Outperform | Hold | 28 | $79.17 | +13.49% | 14.13B |
| Aug 18, 2026 | DRH | DiamondRock Hospitality Company | Morgan Stanley | Main | Equal-Weight | Equal-Weight | — | — | $9.50 | -22.89% | 1.85B |
| Aug 18, 2026 | DT | Dynatrace, Inc. | Citigroup | Main | Buy | Buy | Buy | 43 | $58.67 | +9.99% | 13.65B |
| Aug 18, 2026 | DUOL | Duolingo, Inc. | DA Davidson | Upgrade | Neutral | Buy | — | — | $342.00 | +126.28% | 9.3B |
| Aug 18, 2026 | DUOT | Duos Technologies Group, Inc. | Cantor Fitzgerald | Main | Overweight | Overweight | — | — | $5.50 | -33.25% | 211.91M |
| Aug 18, 2026 | EDIT | Editas Medicine, Inc. | Ladenburg Thalmann | Initiated | — | Buy | — | — | $12.85 | +368.98% | 217.72M |
| Aug 18, 2026 | ELTX | Elicio Therapeutics, Inc. | HC Wainwright & Co. | Reiterated | Buy | Buy | — | — | $1.50 | -25.00% | 144.37M |
| Aug 18, 2026 | ELVN | Enliven Therapeutics, Inc. | Mizuho | Main | Outperform | Outperform | — | — | $52.00 | -4.46% | 1.11B |
| Aug 18, 2026 | ELVN | Enliven Therapeutics, Inc. | Barclays | Initiated | — | Overweight | — | — | $52.00 | -4.46% | 1.11B |
| Aug 18, 2026 | ELVN | Enliven Therapeutics, Inc. | William Blair | Initiated | — | Outperform | — | — | $52.00 | -4.46% | 1.11B |
| Aug 18, 2026 | EPD | Enterprise Products Partners L.P. | Morgan Stanley | Main | Underweight | Underweight | Hold | 13 | $36.00 | -6.98% | 69.77B |
| Aug 18, 2026 | EQIX | Equinix, Inc. | Evercore ISI Group | Main | Outperform | Outperform | Buy | 21 | $930.00 | -6.88% | 73.57B |
| Aug 18, 2026 | ET | Energy Transfer LP | Morgan Stanley | Main | Equal-Weight | Equal-Weight | Buy | 11 | $20.00 | -6.93% | 56.32B |
| Aug 18, 2026 | EVH | Evolent Health, Inc. | JP Morgan | Main | Overweight | Overweight | — | — | $6.00 | +46.34% | 453.39M |
| Aug 18, 2026 | EXR | Extra Space Storage Inc. | Scotiabank | Main | Sector Perform | Sector Perform | — | — | $151.14 | +8.42% | 28.23B |
| Aug 18, 2026 | EYPT | EyePoint Pharmaceuticals, Inc. | RBC Capital | Downgrade | Outperform | Sector Perform | — | — | $33.00 | +676.47% | 1.11B |
| Aug 18, 2026 | EYPT | EyePoint Pharmaceuticals, Inc. | Chardan Capital | Downgrade | Buy | Neutral | — | — | $33.00 | +676.47% | 1.11B |
| Aug 18, 2026 | EYPT | EyePoint Pharmaceuticals, Inc. | HC Wainwright & Co. | Downgrade | Buy | Neutral | — | — | $33.00 | +676.47% | 1.11B |
| Aug 18, 2026 | EYPT | EyePoint Pharmaceuticals, Inc. | Citigroup | Main | Buy | Buy | — | — | $33.00 | +676.47% | 1.11B |
| Aug 18, 2026 | FEMY | Femasys Inc. | Lake Street | Main | Buy | Buy | — | — | — | — | 25.19M |
| Aug 18, 2026 | FN | Fabrinet | JP Morgan | Main | Neutral | Neutral | — | — | $524.50 | +37.11% | 18.93B |
| Aug 18, 2026 | FN | Fabrinet | Needham | Reiterated | Buy | Buy | — | — | $524.50 | +37.11% | 18.93B |
| Aug 18, 2026 | FN | Fabrinet | Barclays | Main | Overweight | Overweight | — | — | $524.50 | +37.11% | 18.93B |
| Aug 18, 2026 | FN | Fabrinet | Rosenblatt | Main | Buy | Buy | — | — | $524.50 | +37.11% | 18.93B |
| Aug 18, 2026 | FSLR | First Solar, Inc. | Morgan Stanley | Main | Overweight | Overweight | Buy | 47 | $276.34 | +33.47% | 29.27B |
| Aug 18, 2026 | FVR | FrontView REIT, Inc. | JP Morgan | Main | Neutral | Neutral | Buy | 10 | $15.75 | -13.65% | 319.33M |
| Aug 18, 2026 | GAP | The Gap, Inc. | TD Cowen | Main | Buy | Buy | — | — | $27.60 | +31.93% | 9.94B |
| Aug 18, 2026 | GRRR | Gorilla Technology Group Inc. | Compass Point | Initiated | — | Buy | — | — | $34.50 | +160.97% | 368.67M |
| Aug 18, 2026 | H | Hyatt Hotels Corporation | Morgan Stanley | Main | Overweight | Overweight | — | — | $164.00 | +0.18% | 15.3B |
| Aug 18, 2026 | HAE | Haemonetics Corporation | BTIG | Main | Buy | Buy | — | — | $82.00 | -22.87% | 4.12B |
| Aug 18, 2026 | HASI | HA Sustainable Infrastructure Capital, Inc. | Morgan Stanley | Main | Overweight | Overweight | — | — | $48.50 | +31.65% | 4.17B |
| Aug 18, 2026 | HBAN | Huntington Bancshares Incorporated | RBC Capital | Reiterated | Outperform | Outperform | Buy | 27 | $19.00 | +13.30% | 26.14B |
| Aug 18, 2026 | HBANL | Huntington Bancshares Incorporated | RBC Capital | Reiterated | Outperform | Outperform | — | — | — | — | 37.66B |
| Aug 18, 2026 | HBANM | Huntington Bancshares Incorporated | RBC Capital | Reiterated | Outperform | Outperform | — | — | $21.00 | +5.63% | 32.65B |
| Aug 18, 2026 | HBANP | Huntington Bancshares Incorporated | RBC Capital | Reiterated | Outperform | Outperform | — | — | — | — | 25.31B |
| Aug 18, 2026 | HGV | Hilton Grand Vacations Inc. | Morgan Stanley | Main | Equal-Weight | Equal-Weight | Buy | 14 | $51.25 | +32.53% | 3.76B |
| Aug 18, 2026 | HON | Honeywell International Inc. | RBC Capital | Main | Outperform | Outperform | Buy | 17 | $240.71 | +19.53% | 123.08B |
| Aug 18, 2026 | HURA | TuHURA Biosciences, Inc. | Citizens | Reiterated | Market Outperform | Market Outperform | — | — | — | — | 52.85M |
| Aug 18, 2026 | IMDX | Insight Molecular Diagnostics Inc. | Needham | Reiterated | Buy | Buy | — | — | $9.00 | +123.88% | 149.63M |
| Aug 18, 2026 | INTS | Intensity Therapeutics, Inc. | HC Wainwright & Co. | Main | Buy | Buy | — | — | $5.00 | +25.63% | 28.29M |
| Aug 18, 2026 | IOVA | Iovance Biotherapeutics, Inc. | Mizuho | Main | Outperform | Outperform | — | — | $14.25 | +53.89% | 744.64M |
| Aug 18, 2026 | IRTC | iRhythm Technologies, Inc | Wells Fargo | Main | Overweight | Overweight | — | — | $210.80 | +83.75% | 5.45B |
| Aug 18, 2026 | IT | Gartner, Inc. | BMO Capital | Main | Market Perform | Market Perform | Buy | 23 | $268.00 | +35.99% | 17.85B |
| Aug 18, 2026 | JAN | JanOne Inc. | Morgan Stanley | Main | Overweight | Overweight | — | — | — | — | 27.14M |
| Aug 18, 2026 | JAN | JanOne Inc. | JP Morgan | Main | Overweight | Overweight | — | — | — | — | 27.14M |
